Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN study
- Hirotsugu Uemura
- , Gaku Arai
- , Hiroji Uemura
- , Hiroyoshi Suzuki
- , Junya Aoyama
- , Tomoyoshi Hatayama
- , Miku Ito
- , Florence Lefresne
- , Sharon McCarthy
- , Suneel Mundle
- , Jin He
- , Kim N. Chi
Research output: Contribution to journal › Article › peer-review